With courageous science, creativity, and compassion, we are committed to the research for delivering life-changing medicines.
Luis Supply Chain at Apellis
Leaders in the research of targeted C3 therapies, we aim to develop new therapies for a broad range of debilitating diseases that are driven by excessive activation of the complement cascade, including those within hematology, ophthalmology, neurology and nephrology.
We are exploring C3, the central protein of the complement system. This includes research into a broad range of serious diseases driven by uncontrolled or excessive activation of the